{"id":251341,"date":"2021-11-19T00:00:00","date_gmt":"2021-11-19T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/products\/research-reports\/report\/epidcv0029-biopharma-pulmonary-hypertension-epidemiology-middle\/"},"modified":"2026-04-25T11:31:49","modified_gmt":"2026-04-25T11:31:49","slug":"epidcv0029-biopharma-pulmonary-hypertension-epidemiology-middle-east-africa","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/epidcv0029-biopharma-pulmonary-hypertension-epidemiology-middle-east-africa\/","title":{"rendered":"Pulmonary Hypertension &#8211; Epidemiology &#8211; Middle East &#038; Africa"},"content":{"rendered":"<p>Clarivate Epidemiology\u2019s coverage of pulmonary hypertension (<abbr data-abbreviation-entity=\"5930\" title=\"pulmonary hypertension\">PH<\/abbr>) comprises epidemiological estimates of key patient populations in 14 mature and emerging pharmaceutical markets worldwide. We report the prevalence of <abbr title=\"pulmonary hypertension\">PH<\/abbr> for each country, as well as annualized case counts projected to the national population.<\/p>\n<p>Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets and 10 years for the other countries covered in this report.<\/p>\n<p>Clarivate Epidemiology\u2019s <abbr title=\"pulmonary hypertension\">PH<\/abbr> forecast will answer the following questions:<\/p>\n<ul class=\"round-bullets\">\n<li>Of all people with <abbr title=\"pulmonary hypertension\">PH<\/abbr>, how many in each of the major mature pharmaceutical markets have been formally diagnosed?<\/li>\n<li>Of all people diagnosed <abbr title=\"pulmonary hypertension\">PH<\/abbr>, how many in each of the major mature pharmaceutical markets are drug-treated?<\/li>\n<li>How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of <abbr title=\"pulmonary hypertension\">PH<\/abbr> over the forecast period?<\/li>\n<li>How will changes in the levels of exposure to known risk or protective factors affect the number of people at high-risk for <abbr title=\"pulmonary hypertension\">PH<\/abbr>?<\/li>\n<\/ul>\n<p>All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to <span class=\"abbreviation-guard\">MS <\/span>Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.<\/p>\n<p>Clarivate Epidemiology provides at least 10 years of forecast data for the following PH patient populations:<\/p>\n<ul class=\"round-bullets\">\n<li>Diagnosed prevalent cases of <abbr data-abbreviation-entity=\"5930\" title=\"pulmonary hypertension\">PH<\/abbr>.<\/li>\n<li>Diagnosed prevalent cases of <abbr title=\"pulmonary hypertension\">PH<\/abbr> by subgroup.<\/li>\n<li>Diagnosed prevalent cases of pulmonary arterial hypertension by drug treatment.<\/li>\n<\/ul>\n<p>Note: Coverage may vary by country and region.<\/p>\n","protected":false},"template":"","class_list":["post-251341","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-cardiovascular","biopharma-therapy-areas-hypertension","biopharma-therapy-areas-pulmonary-hypertension","biopharma-product-epidemiology","biopharma-geography-middle-east-africa","biopharma-date-950"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251341","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":10,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251341\/revisions"}],"predecessor-version":[{"id":576352,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251341\/revisions\/576352"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=251341"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}